VaccineSpecial characteristics recognition

After the implementation of the latest amendment to the Biosafety Law in 2025,the vaccine production equipmentFormeda dual regulatory system: In addition to the regular import process for mechanical and electrical products,it is also necessary to pass the biosafety approval of the provincial drug regulatory authorities.According to the data from the General Administration of Customs in January 2025,the average customs clearance time for imported equipment involving vaccine production lines is 18 working days longer than that for ordinary equipment,and 68% of the delays are due to the biosafety certification process.

Decomposition of Key Operation Processes

• Pre-filingstage
  • Applyforabiosafetypermit90daysinadvance(validityperiodshortenedto12months).
  • Preparethetechnicalwhitepaperforequipmentparameters(mustincludemicrobialprotectionlevelcertification).
• Key points for on-site inspection
  • Leakagedetection(usingthepositivepressuretestmethod)
  • Residuesampling(focusingonthemediumresidueindex)

Solutions to Typical Problems

When a certain vaccine company imported a freeze-drying unit from Germany in March 2025,it encountered problems due to the following reasons:Differences in technical parameter descriptionsIt caused customs clearance to be blocked.We prepared in advance toThree-party Certification Comparison Table(CE Certification and NMPA Standard Corresponding Items),complete the technical review within 48 hours to avoid incurring demurrage charges.

• Top3CommonCustomsClearanceObstacles:
  • Incompletebiosafetyapprovalmaterials(accountingfor42%)
  • Incorrectequipmentclassification(particularlydisputesovertheclassificationofsterilizationequipment)
  • Thetechnicalvalidationdocumenthasexpired(pleasenotethenewGMPstandardin2025).

Criteria for Proxy Service Selection

Compared with the customs clearance data from 2024 to 2025,professional agents can improve the efficiency of vaccine equipment imports by 40%.It is recommended to focus on evaluating the agents’ capabilities in this regard.Four core competencies:

• Biosafetyapprovalgreenchannelresources
• LocalizedDrugRegulatoryFilingSystemOperationPermissions
• EmergencyTechnicalDisputeResolutionExpertPanel
• Real-timeMonitoringSystemforColdChainTransportation

Forward-looking risk prevention and control

In response to the new MDR regulation implemented by the European Union in 2025,it is recommended to require suppliers to provide the necessary documents and certifications at the procurement stage.Dual Compliance StatementA domestic vaccine company has successfully reduced the customs inspection time to three hours by using pre-installed equipment to track traceability chips.This solution has been included in the bonus points for AEO certification by customs in 2025.